The 8 analysts offering 12-month price forecasts for Health Catalyst Inc have a median target of 49.00, with a high estimate of 55.00 and a low estimate of 46.00. The median estimate represents a +43.61% increase from the last price of 34.12.
The current consensus among 9 polled investment analysts is to Buy stock in Health Catalyst Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.29
Reporting Date Feb 18
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.